Skip to main content
SpringerLink
Log in

Administration of neutralizing antibody against rabbit IL-1 receptor antagonist exacerbates lipopolysaccharide-induced arthritis in rabbits

  • Original Research Papers
  • Published:
Inflammation Research Aims and scope Submit manuscript

Abstract

Endogenous IL-1 receptor antagonist (IL-1ra) may down-regulate part of IL-1 actions. We examined the participation of endogenous IL-1ra in the production of IL-1β in vitro. Macrophages cultured on adherent IgG produced a 100-fold molar excess of IL-1ra, compared with IL-1β. In the presence of a neutralizing monoclonal antibody (mAb) against rabbit IL-1ra, the production of antigenic IL-1β increased by 20–60%. Since the molar ratio of IL-1ra over IL-1 was 160- to 400-fold in synovial fluid (SF) of lipopolysaccharide (LPS)-induced arthritis, we examined the functional role of endogenous IL-1ra in the regulation of inflammatory responses. When measured in the presence of anti-IL-1ra mAb, masked IL-1 activity in SF became evident, with a 3- to 4-fold increment. The administration of anti-IL-1ra mAb with LPS into rabbit knee joints increased the IL-1 activity 4-fold and the production of antigenic IL-1β by 30–50%. The treatment also enhanced by 20–40% LPS-induced leukocyte infiltration and protein leakage. Therefore, endogenous IL-1ra apparently acts as a down-regulating factor for limiting delecterious effects of IL-1 by masking the biological activity and by inhibiting the production.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. di Giovine FS, Duff GW. Interleukin 1: the first interleukin. Immunol Today 1990;11:13–20.

    Article  PubMed  Google Scholar 

  2. Dinarello CA. Interleukin-1 and its biologically related cytokines. Adv Immunol 1989;44:153–205.

    PubMed  Google Scholar 

  3. Dinarello CA. The biology of interleukin-1. Chem Immunol 1992;51:1–32.

    PubMed  Google Scholar 

  4. Dinarello CA. Modalities for reducing interleukin 1 activity in disease. Immunol Today 1993;14:260–4.

    Article  PubMed  Google Scholar 

  5. Carter DB, Deibel MJ, Dunn CJ, Tomich CS, Laborde AL, Slightom JL, et al. Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist protein. Nature 1990:344:633–8.

    Article  PubMed  Google Scholar 

  6. Eisenberg SP, Evans RJ, Arend WP, Verderber E, Brewer MT, Hannum CH, et al. Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist. Nature 1990;343:341–6.

    Article  PubMed  Google Scholar 

  7. Arend WP. Interleukin-1 receptor antagonist. Adv Immunol 1993;54:167–227.

    PubMed  Google Scholar 

  8. Dinarello CA, Thompson RC. Blocking IL-1: interleukin 1 receptor antagonistin vivo and in vitro. Immunol Today 1991;12:404–10.

    Article  PubMed  Google Scholar 

  9. Fisher CJ, Slotman GJ, Opal SM, Pribble JP, Bone RC, Emmanuel G, et al. Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: a randomized, open-label, placebo-controlled multicenter trial. Crit Care Med 1994;22:12–21.

    PubMed  Google Scholar 

  10. Lebsack ME, Paul CC, Martindale MA. A dose- and regimenranging study of IL-1 receptor antagonist in patients with rheumatoid arthritis. Arthr. Rheum 1993;36:S39.

    Google Scholar 

  11. Antin JH, Weinstein HJ, Guinan EC, McCarthy P, Bierer BE, Gilliland DG, et al. Recombinant human interleukin-1 receptor antagonist in the treatment of steroid-resistant graftversus-host disease. Blood 1994;84;1342–8.

    PubMed  Google Scholar 

  12. Matsukawa A, Ohkawara S, Maeda T, Takagi K, Yoshinaga M. Production of IL-1 and IL-1 receptor antogonist and the pathological significance in lipopolysaccharide-induced arthritis in rabbits. Clin Exp Immunol 1993;93:206–11.

    PubMed  Google Scholar 

  13. Matsukawa A, Furukawa S, Ohkawara S, Takagi K, Yoshinaga M. Development of a neutralizing monoclonal antibody against rabbit IL-1 receptor antagonist and utilization for ELISA and measurement of masked IL-1 activity in biological materials. Immunol Invest 1994;23:129–42.

    PubMed  Google Scholar 

  14. Chikanza IC, Roux LP, Dayer JM, Panayi GS. Dysregulation of the in vivo production of interleukin-1 receptor antagonist in patients with rheumatoid arthritis. Pathogenetic implications. Arthr Rheum 1995;38:642–8.

    Google Scholar 

  15. Miller LC, Lynch EA, Isa S, Logan JW, Dinarello CA, Steere AC. Balance of synovial fluid IL-1β and IL-1 receptor antagonist and recovery from Lyme arthritis. Lancet 1993;341:146–8.

    Article  PubMed  Google Scholar 

  16. Casini RV, Kam L, Chong YJ, Fiocchi C, Pizarro TT, Cominelli F, Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation. J Immunol 1995;154:2434–40.

    PubMed  Google Scholar 

  17. Nisonoff A, Wissler FC, Lipman LN. Properties of the major component of a peptic digest of rabbit antibody. Science 1960;132:1770–1.

    PubMed  Google Scholar 

  18. Matsukawa A, Mori S, Ohkawara S, Maeda T, Tanase S, Edamitsu S, et al. Production, purification and characterization of a rabbit recombinant IL-1 receptor antagonist Biomed Res 1992;13:269–77.

    Google Scholar 

  19. Goto F, Goto K, Mori S, Ohkawara S, Yoshinaga M. Biosynthesis of interleukin-1β at inflammatory site in rabbits: kinetics and producing cells. Br J Exp Pathol 1989;70:597–606.

    PubMed  Google Scholar 

  20. Flick DA, Gifford GE. Comparison of in vitro cell cytotoxic assays for tumor necrosis factor. J Immunol Meth 1984;68:167–75.

    Article  Google Scholar 

  21. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248–54.

    PubMed  Google Scholar 

  22. Goto F, Goto K, Miyata T, Ohkawara S, Takao T, Mori S, et al. interleukin-1 receptor antagonist in inflammatory exudate cells of rabbits. Production, purification and determination of primary structure. Immunology 1992;77:235–44.

    PubMed  Google Scholar 

  23. Dripps DJ, Brandhuber BJ, Thompson RC, Eisenberg SP. Interleukin-1 (IL-1) receptor antagonist binds to the 80-kDa IL-1 receptor but does not initiate IL-1 signal transduction. J Biol Chem 1991;266:10331–6.

    PubMed  Google Scholar 

  24. Dripps DJ, Verderber E, Ng RK, Thompson RC, Eisenberg SP. Interleukin-1 receptor antagonist binds to the type II interleukin-1 receptor on B cells and neutrophils. J Biol Chem 1991;266:20311–5.

    PubMed  Google Scholar 

  25. Granowitz EV, Clark BD, Mancilla J, Dinarello CA. Interleukin-1 receptor antagonist competitively inhibits the binding of interleukin-1 to the type II interleukin-1 receptor. J Biol Chem 1991;266:14147–50.

    PubMed  Google Scholar 

  26. Dinarello CA, Ikejima T, Warner SJ, Orencole SF, Lonnemann G, Cannon JG, et al. Interleukin 1 induces interleukin 1. I. Induction of circulating interleukin 1 in rabbits in vivo and in human mononuclear cells in vitro. J Immunol 1987;139:1902–10.

    PubMed  Google Scholar 

  27. Chensue SW, Bienkowski M, Eessalu TE, Warmington KS, Hershey SD, Lukacs NW, et al. Endogenous IL-1 receptor antagonist protein (IRAP) regulates schistosome egg granuloma formation and the regional lymphoid response. J Immunol 1993;151:3654–62.

    PubMed  Google Scholar 

  28. Ferretti M, Casini RV, Pizarro TT, Eisenberg SP, Nast CC, Cominelli F. Neutralization of endogenous IL-1 receptor antagonist exacerbates and prolongs inflammation in rabbit immune colitis. J Clin Invest 1994:94:449–53.

    PubMed  Google Scholar 

  29. Fujioka N, Mukaida N, Harada A, Akiyama M, Kasahara T, Kuno K, et al. Preparation of specific antibodies against murine IL-1ra and the establishment of IL-1ra as an endogenous regulator of bacteria-induced fulminant hepatitis in mice. J Leukoc Biol 1995;58:90–8.

    PubMed  Google Scholar 

  30. Firestein GS, Boyle DL, Yu C, Paine MM, Whisenand TD, Zvaifler NJ, et al. Synovial interleukin-1 receptor antagonist and interleukin-1 balance in rheumatoid arthritis. Arthr Rheum 1994;37:644–52.

    Google Scholar 

  31. Chomarat P, Vannier E, Dechanet J, Rissoan MC, Banchereau J, Dinarello CA, et al. Balance of IL-1 receptor antogonist/IL-1β in rheumatoid synovium and its regulation by IL-4 and IL-10. J Immunol 1995;154:1432–9.

    PubMed  Google Scholar 

  32. Zvaifler NJ. The immunopathology of joint inflammation in rheumatoid arthritis. Adv Immunol 1973;16:265–336.

    PubMed  Google Scholar 

  33. Chantry D, Winearls CG, Maini RN, Feldmann M. Mechanism of immune complex-mediated damage: induction of interleukin 1 by immune complexes and synergy with interferon-γ and tumor necrosis factor-α. Eur J Immunol 1989;19:189–92.

    PubMed  Google Scholar 

  34. Marsh CB, Gadek JE, Kindt GC, Moore SA, Wewers MD. Monocyte Fcγ receptor cross-linking induces IL-8 production. J Immunol 1995;155:161–7.

    Google Scholar 

  35. Colotta F, Re F, Muzio M, Bertini R, Polentarutti N, Sironi M, et al. Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. Science 1993;261:472–5.

    PubMed  Google Scholar 

  36. Colotta F, Dower SK, Sims JE, Mantovani A. The type II ‘decoy’ receptor: a novel regulatory pathway for interleukin 1. Immunol Today 1994;15:562–6.

    Article  PubMed  Google Scholar 

  37. Bristulf J, Bartfai T. Interleukin-1β and tumour necrosis factor-α stimulate the mRNA expression of interleukin-1 receptors in mouse anterior pituitary AtT-20 cells. Neurosci Lett 1995;187:53–6.

    Article  PubMed  Google Scholar 

  38. Haranaka K, Satomi N, Sakurai A, Nariuchi H. Purification and partial amino acid sequence of rabbit tumor necrosis factor. Int J Cancer 1985;36:395–400.

    PubMed  Google Scholar 

  39. Ikejima T, Okusawa S, Ghezzi P, van der Meer JWM, Dinarello CA. Interleukin-1 induces tumor necrosis factor (TNF) in human peripheral blood mononuclear cells in vitro and a circulating TNF-like activity in rabbits. J Infect Dis 1990;162:215–23.

    PubMed  Google Scholar 

  40. Marsh CB, Moore SA, Pope HA, Wewers MD. IL-1ra suppresses endotoxin-induced IL-1β and TNF-α release from mononuclear phagocytes. Am J Physiol 1994;267:L39–45.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, Kumamoto University School of Medicine, 2-2-1, Honjo, 860, Kumamoto, Japan

    T. Fukumoto, A. Matsukawa, S. Ohkawara & M. Yoshinaga

  2. Department of Orthopedics, Kumamoto University School of Medicine, 2-2-1, Honjo, 860, Kumamoto, Japan

    T. Fukumoto & K. Takagi

Authors
  1. T. Fukumoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Matsukawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. Ohkawara
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. K. Takagi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M. Yoshinaga
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

accepted by M. Katori

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fukumoto, T., Matsukawa, A., Ohkawara, S. et al. Administration of neutralizing antibody against rabbit IL-1 receptor antagonist exacerbates lipopolysaccharide-induced arthritis in rabbits. Inflamm Res 45, 479–485 (1996). https://doi.org/10.1007/BF02252320

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02252320

Key words

Search

Navigation